Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1975)	10/1/2000 6:10:50 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

This week's BioCentury..... "In the past 12 months, 55 U.S. companies have gone public, raising $5.3 billion, while 24 European companies have raised $1.8 billion in IPOs. This sheer proliferation raises the question of whether the market can continue to feed all of these mouths until they turn the corner on profitability. But industry players aren't too concerned with oversupply because in their eyes the demand for biotechnology investments - both on the primary and secondary markets - has never been stronger." Well, yeah, but....... As always, enjoy it while you can. And, no doubt, that last line is correct..... demand has never been stronger. This thread is a convenient chronicle.